Chorea News and Research

RSS
Deuteration offers alternative chorea treatment for Huntington disease patients

Deuteration offers alternative chorea treatment for Huntington disease patients

Diseases that cause skin-related problems can also trigger serious neurological conditions

Diseases that cause skin-related problems can also trigger serious neurological conditions

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences, Mitsubishi Tanabe to develop and commercialize NBI-98854 in select Asian markets

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Neurocrine Biosciences' NBI-98854 drug gets breakthrough designation for tardive dyskinesia

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

Cedars-Sinai experts to present free conference on dystonia for patients, families and caregivers

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

HSG conducts clinical trial with novel drug formulation for treating Huntington disease

HSG conducts clinical trial with novel drug formulation for treating Huntington disease

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

TP PCR methodology may help streamline genetic testing for Huntington's

TP PCR methodology may help streamline genetic testing for Huntington's

New AAN guideline recommends several treatments for people with Huntington's chorea

New AAN guideline recommends several treatments for people with Huntington's chorea

Measuring wellbeing in Huntington’s disease

Measuring wellbeing in Huntington’s disease

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases